Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorCentre Antoine Lacassagne

About this trial

A single-center, randomized (1:1) open-label, prospective, stratified study with two parallel arms, designed to evaluate adherence to the adapted physical activity (APA) program for patients participating in an APA program and to compare changes in fatigue at 3 months in patients who have completed adjuvant systemic chemotherapy for cancer and are participating in an APA program.

Eligibility criteria

Qualifiers

Patients aged 18 to 75 years old,

Histologically proven non-metastatic adenocarcinoma of breast, colorectal, ovarian, pancreatic, biliary, or gastric origin,

Adjuvant chemotherapy completed less than 3 months ago (excluding hormone therapy),

PS 0 or 1 according to the World Health Organization (WHO) scale,

Disqualifiers

New cancer treatment planned (excluding hormone therapy),

Patient who has received adjuvant immunotherapy,

Cardiological contraindication to the program

Decompensated or unstable chronic conditions

Trial design

Treatments tested in this trial

  • APA program

Treatment groups

98 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Centre Antoine Lacassagne

Lead sponsor

Centre Hospitalier Universitaire de Nice

Collaborator